Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Invivyd ( (IVVD) ) has provided an update.
On November 24, 2025, Invivyd, Inc. announced the selection of VBY329, a potential best-in-class monoclonal antibody candidate for the prevention of Respiratory Syncytial Virus (RSV) in newborns, infants, and children. VBY329, developed using Invivyd’s proprietary technology, shows higher potency and improved resistance compared to existing RSV treatments. The company aims for IND readiness by the second half of 2026, targeting the growing pediatric RSV prophylaxis market, which is expected to reach $3-$4 billion globally by 2030. This development could significantly enhance Invivyd’s industry positioning by providing a novel solution in a rapidly expanding market.
The most recent analyst rating on (IVVD) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Invivyd stock, see the IVVD Stock Forecast page.
Spark’s Take on IVVD Stock
According to Spark, TipRanks’ AI Analyst, IVVD is a Neutral.
Invivyd’s overall stock score reflects significant financial and technical weaknesses, marked by ongoing losses and bearish trends. While recent corporate developments offer a glimpse of potential strategic improvement, these are overshadowed by the current financial instability and weak market sentiment.
To see Spark’s full report on IVVD stock, click here.
More about Invivyd
Invivyd, Inc. is a biopharmaceutical company focused on delivering protection from serious viral infectious diseases, starting with SARS-CoV-2. The company utilizes a proprietary technology platform to develop best-in-class antibodies, and it received emergency use authorization from the U.S. FDA in March 2024 for a monoclonal antibody in its pipeline.
Average Trading Volume: 10,669,672
Technical Sentiment Signal: Buy
Current Market Cap: $582.8M
See more data about IVVD stock on TipRanks’ Stock Analysis page.